The natural history of multiple sclerosis with childhood onset

Christel Renoux1, Sandra Vukusic, Christian Confavreux

  • 1Service de Neurologie A and EDMUS Coordinating Center, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, Bron, France.

Insights

Childhood-onset multiple sclerosis (MS) progresses slower but reaches milestones at a younger age, challenging favorable prognosis notions. The underlying disease biology appears similar across all age groups.

Area of Science:

  • Neurology
  • Pediatric Neurology
  • Autoimmune Diseases

Background:

  • Childhood-onset multiple sclerosis (MS) is rare, affecting less than 5% of cases.
  • Exacerbating-remitting forms are the most common initial presentation.

Purpose of the Study:

  • To analyze the characteristics and long-term evolution of childhood-onset MS.
  • To compare disease progression and prognosis between childhood-onset and adult-onset MS.

Main Methods:

  • Retrospective analysis of childhood-onset multiple sclerosis cases.
  • Comparison of disease milestones and progression rates with adult-onset MS cohorts (e.g., KIDMUS study).

Main Results:

  • Childhood-onset MS patients experience a longer time to reach secondary progressive phase and disability landmarks compared to adult-onset MS.
  • Despite slower progression, childhood-onset MS patients reach these critical phases at a younger age.
  • Clinical phenotype is influenced by age at onset, but underlying pathophysiology remains consistent.

Conclusions:

  • Childhood-onset MS has a complex long-term evolution, with delayed milestones but earlier achievement of disease stages.
  • The notion of a more favorable prognosis for childhood-onset MS is challenged.
  • Age at onset primarily affects MS clinical presentation, not the core biological disease process.

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Psychological and Sociocultural Causes of Schizophrenia01:29

Psychological and Sociocultural Causes of Schizophrenia

Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Biological Causes of Schizophrenia01:29

Biological Causes of Schizophrenia

Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...